Son güncelleme :
28/04/2024
Infostab
Listeler
Listeler
Uyumluluk arayın
Y site uyumluluk tablosu
Kaynaklar
Araştırma Takımlar
Valistab
Afiş
Bağlantıları
Sponsorlar
Yazar
Kullanıcı rehberi
Bültenini
Araştırma Takımlar - University Hospital of Angers, Pharmacy Department
University Hospital of Angers, Pharmacy Department
Angers
frederic.lagarce@univ-angers.fr
Kaynaklar
(7)
1
Stability of a high-concentrated aqueous solution of idarubicin stored in a polypropylene syringe for transarterial chemoembolization
Bourcier B, Lagarce R, Lebreton V. (vincent.lebreton@chu-angers.fr)
J Pharm Biomed Anal -
2022
-
2
New liquid oral formulations of hydroxychloroquine: a physicochemical stability study.
Lebreton V, Bourcier B, Cosson K, Lagarce F, Spiesser-Robelet L, Vrignaud S. (vincent.lebreton@univ-angers.fr)
Pharmaceutical Technology in Hospital Pharmacy -
2021
- ; 6(1): 20200013.
3
Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation.
Gautier E, Saillard J, Deshayes C, Vrignaud S, Lagarce F, Briot T. (thomas.briot@univ-angers.fr)
Pharmaceutical Technology in Hospital Pharmacy -
2018
- ;3,4:219-226
4
Stability of Reconstituted and Diluted Mitomycin C Solutions in Polypropylene Syringes and Glass Vials.
Briot T, Truffaut C, Le Quay L, Lebreton A, Lagarce F. (thomas.briot@univ-angers.fr)
Pharmaceutical Technology in Hospital Pharmacy -
2016
- ;1,2:83-89
5
Formulation and charaterization of 0,1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas.
Bougueon G, Lagarce F, Martin L, Pailhoriès H, Bastiat G, Vrignaud S. (sandy-vrignaud@hotmail.fr)
Int J Pharm -
2016
- ; 509 : 279:284.
6
Stability of micafungin sodium solutions at different concentrations in glass bottles and syringes.
Briota Th, Vrignaud S, Lagarce F. (frederic.lagarce@univ-angers.fr )
Int J Pharm -
2015
- ; 492 : 137?140.
7
Design and stability study of a paediatric oral solution of methotrexate 2 mg/ml
Vrignaud S, Briot T, Launay A, Kempf M, Lagarce F. (sandy.v@laposte.net)
Int J Pharm -
2015
- ; 487 : 270-273.
Moleküller okudu
(7)
Ceftazidime
Hydroxychloroquine sulfate
Idarubicin hydrochloride
Methotrexate
Micafungin
Mitomycin
Sirolimus
Mentions Légales
